nach oben

Current Pulmonology Reports

Erschienen in:

11.04.2017 | Nutrition and Critical Care (J Patel, Section Editor)

Immunonutrition in Acute Respiratory Distress Syndrome

verfasst von: Masooma Aqeel, Shahryar Ahmad, Jayshil J. Patel, Todd W. Rice

Erschienen in: Current Pulmonology Reports | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Dietary supplementation with nutrients such as glutamine and omega-3 fatty acids to modulate/boost host immunity in critical illness is a new concept. We review current evidence (animal and human studies) on the role of immunonutrition in acute respiratory distress syndrome (ARDS).

Recent Findings

Dietary supplementation during stress states (ARDS) with omega-3 fatty acids has been shown to attenuate inflammation and improve lung microvascular permeability in animals. In humans, omega-3 fatty acid supplementation has shown mixed results. While studies show improvement in oxygenation and lung mechanics, a recent study demonstrated increased mortality with omega-3 fatty acids. Similarly, animal studies suggest that lower glutamine levels are associated with worse outcomes in surgical and septic patients. But, a recent study in humans has shown an increased trend towards all-cause mortality.

Summary

Current evidence is conflicting and does not support use of immune-modulating therapies (glutamine or omega-3 fatty acids) in ARDS.

Mariette C. Immunonutrition. J Visc Surg. 2015;152(Suppl 1):S14–7.PubMed

Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319–23.PubMed

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee J Crit Care. 1994;9(1):72–81.PubMed

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818–24.PubMed

Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.PubMed

Tomashefski JF. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000;21(3):435–66.PubMed

Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27(4):337–49.PubMed

Brosnan JT. Interorgan amino acid transport and its regulation. J Nutr. 2003;133(6 Suppl 1):2068S–72S.PubMed

Planas M, Schwartz S, Arbós MA, Farriol M. Plasma glutamine levels in septic patients. JPEN J Parenter Enteral Nutr. 1993;17(3):299–300.PubMed

10.

Wischmeyer PE, Musch MW, Madonna MB, Thisted R, Chang EB. Glutamine protects intestinal epithelial cells: role of inducible HSP70. Am J Phys. 1997;272(4 Pt 1):G879–84.

11.

•• Pierre JF, Heneghan AF, Lawson CM, Wischmeyer PE, Kozar RA, Kudsk KA. Pharmaconutrition review: physiological mechanisms. JPEN J Parenter Enteral Nutr. 2013;37(5 Suppl):51S–65S. This review comprehensively explains the pharmacological effects of various macronutrients and micronutrients on the immune-system PubMed

12.

Singleton KD, Beckey VE, Wischmeyer PE. Glutamine prevents activation of NF-kappa B and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock. 2005;24(6):583–9.PubMed

13.

Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355–74.PubMedPubMedCentral

14.

King MW. The Medical Biochemistry Page: eicosanoid synthesis and metabolism: prostaglandins, thromboxanes, leukotrienes, lipoxins 1996–2016 [Available from: http://themedicalbiochemistrypage.org/.

15.

• García de Acilu M, Leal S, Caralt B, Roca O, Sabater J, Masclans JR. The role of omega-3 polyunsaturated fatty acids in the treatment of patients with acute respiratory distress syndrome: a clinical review. Biomed Res Int. 2015;2015:653750. This review covers recent data and trials on the use of omega-3 polyunsaturated fatty acids in ARDS patients PubMedPubMedCentral

16.

de Alaniz MJ, Marra CA. Glucocorticoid and mineralocorticoid hormones depress liver delta 5 desaturase activity through different mechanisms. Lipids. 1992;27(8):599–604.PubMed

17.

Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr. 2008;32(6):596–605.PubMed

18.

Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000;130(8):1925–31.PubMed

19.

Murray MJ, Kumar M, Gregory TJ, Banks PL, Tazelaar HD, DeMichele SJ. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. Am J Phys. 1995;269(6 Pt 2):H2090–9.

20.

Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Claycombe KJ, et al. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med. 1997;25(3):523–32.PubMed

21.

Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med. 1997;25(7):1198–206.PubMed

22.

Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral nutrition in ARDS study group. Crit Care Med. 1999;27(8):1409–20.PubMed

23.

Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med. 2011;39(7):1655–62.PubMedPubMedCentral

24.

Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34(9):2325–33.PubMed

25.

Elamin EM, Miller AC, Ziad S. Immune enteral nutrition can improve outcomes in medical-surgical patients with ARDS: a prospective randomized controlled trial. J Nutr Disord Ther. 2012;2:109.PubMedPubMedCentral

26.

Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033–8.PubMed

27.

•• Rice TW, Wheeler AP, Thompson BT, de Boisblanc BP, Steingrub J, Rock P, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306(14):1574–81. This large-scale randomized (phase III ARDSNet) clinical trial had to be terminated early after it showed worsened outcomes in ARDS patients supplemented with omega-3 fatty acids. PubMedPubMedCentral

28.

Parish M, Valiyi F, Hamishehkar H, Sanaie S, Asghari Jafarabadi M, Golzari SE, et al. The effect of omega-3 fatty acids on ARDS: a randomized double-blind study. Adv Pharm Bull. 2014;4(Suppl 2):555–61.PubMedPubMedCentral

29.

Calder PC. A matter of fat. JPEN J Parenter Enteral Nutr. 2015;39(7):756–8.PubMed

30.

The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342(18):1301–8.

31.

Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, de Boisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75.PubMed

32.

Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14(6):523–35.PubMed

33.

Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54–61.PubMed

34.

• Santacruz CA, Orbegozo D, Vincent JL, Preiser JC. Modulation of dietary lipid composition during acute respiratory distress syndrome: systematic review and meta-analysis. JPEN J Parenter Enteral Nutr. 2015;39(7):837–46. An important meta-analysis of current randomized clinical trials showcasing the role of omega-3 fatty acid supplementation. It highlights that benefits were more pronounced when omega-3 fatty acids were compared to a high lipid supplementation rather than benefits from omega-3 fatty acid use alone. PubMed

35.

Mesejo A, Sánchez Álvarez C, Arboleda Sánchez JA, (SEMICYUC-SENPE) SSoICMaCU-SSoPaEN. Guidelines for specialized nutritional and metabolic support in the critically ill-patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): obese patient. Med Int. 2011;35(Suppl 1):57–62.

36.

Newsholme P, Procopio J, Lima MM, Pithon-Curi TC, Curi R. Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem Funct. 2003;21(1):1–9.PubMed

37.

Vinnars E, Bergstöm J, Fürst P. Influence of the postoperative state on the intracellular free amino acids in human muscle tissue. Ann Surg. 1975;182(6):665–71.PubMedPubMedCentral

38.

Roth E, Funovics J, Mühlbacher F, Schemper M, Mauritz W, Sporn P, et al. Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr. 1982;1(1):25–41.PubMed

39.

Rodas PC, Rooyackers O, Hebert C, Norberg Å, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond). 2012;122(12):591–7.

40.

D'Eufemia P, Finocchiaro R, Celli M, Tote J, Ferrucci V, Zambrano A, et al. Neutrophil glutamine deficiency in relation to genotype in children with cystic fibrosis. Pediatr Res. 2006;59(1):13–6.PubMed

41.

Plumley DA, Souba WW, Hautamaki RD, Martin TD, Flynn TC, Rout WR, et al. Accelerated lung amino acid release in hyperdynamic septic surgical patients. Arch Surg. 1990;125(1):57–61.PubMed

42.

Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med. 2005;33(6):1206–13.PubMed

43.

•• Oliveira GP, de Abreu MG, Pelosi P, Rocco PR. Exogenous glutamine in respiratory diseases: myth or reality? Nutrients. 2016;8(2):76. Comprehensive review article for readers on the current evidence of use of glutamine in acute lung injury (mostly animal studies) PubMedPubMedCentral

44.

Hou YC, Pai MH, Chiu WC, Hu YM, Yeh SL. Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. Am J Physiol Lung Cell Mol Physiol. 2009;296(3):L288–95.PubMed

45.

Zhang F, Wang X, Pan L, Wang W, Li N, Li J. Glutamine attenuates lipopolysaccharide-induced acute lung injury. Nutrition. 2009;25(6):692–8.PubMed

46.

Lai CC, Liu WL, Chen CM. Glutamine attenuates acute lung injury caused by acid aspiration. Nutrients. 2014;6(8):3101–16.PubMedPubMedCentral

47.

Fernandez-Bustamante A, Agazio A, Wilson P, Elkins N, Domaleski L, He Q, et al. Brief glutamine pretreatment increases alveolar macrophage CD163/heme oxygenase-1/p 38-MAPK dephosphorylation pathway and decreases capillary damage but not neutrophil recruitment in IL-1/LPS-insufflated rats. PLoS One. 2015;10(7):e0130764.PubMedPubMedCentral

48.

• Heyland D, Wischmeyer PE, Day AG, Group CCCT. Glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;369(5):484–5. Randomized controlled trial on ICU-patients in multi-organ failure. Glutamine supplementation increased all cause mortality at 28 days PubMed

49.

Dushianthan A, Cusack R, Grocott M. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults (Protocol).Cochrane Database of Systematic Reviews 2016. [Systematic Review]. In press 2016.

50.

Headland SE, Norling LV. The resolution of inflammation: principles and challenges. Semin Immunol. 2015;27(3):149–60.PubMed

51.

Martindale RG, Warren MM, McClave SA. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils? Curr Opin Clin Nutr Metab Care. 2016;19(2):151–4.PubMed

52.

McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.PubMed

53.

Patel JJ, Kha V, Butler D, Kozeniecki M, Martindale R, Allen K. Organ-specific nutrition: one for the history books or still an active player? Curr Surg Rep 2016; 4 (28).

Titel: Immunonutrition in Acute Respiratory Distress Syndrome
verfasst von: Masooma Aqeel
Shahryar Ahmad
Jayshil J. Patel
Todd W. Rice
Publikationsdatum: 11.04.2017
Verlag: Springer US
Erschienen in: Current Pulmonology Reports / Ausgabe 2/2017
Elektronische ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-017-0171-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Frauen bekommen seltener eine intensive Statintherapie

30.04.2024 Statine Nachrichten

Frauen in den Niederlanden erhalten bei vergleichbarem kardiovaskulärem Risiko seltener eine intensive Statintherapie als Männer. Ihre LDL-Zielwerte erreichen sie aber fast ähnlich oft.

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Non-traumatic Pulmonary Emergencies in the Deployed Setting

Screening Programs for Obstructive Sleep Apnea

Impact of High Altitude on Military Operations

Traumatic Brain Injury in Combat Trauma

Hypoventilation Syndromes